Yann04
Senior Member (Voting Rights)
Well there are a very specific set of symptoms and characteristics that nearly everyone with severe and very severe (and many people with mild-moderate) ME/CFS fits into. They roughly fit the ICC and represent somewhere around 0.1-0.5% of the population. These people experience severe functional limitation due to a disease involving immune mechanisms which presents as a deterioration of the illness after any exertion over baseline. This could be as simple as seeing too bright lights, or having to make a decision.
Further down the spectrum, are people who are functionally limited by unexplained fatigue that seems to get worse with activity. Using this definition you get much higher percentages, and biological abnormalities are much harder to find because the population becomes much more heterogenous.
If you water this down even more, you get the kind of thing we saw in that iranian study, basically just fatigue, and you start having really high prevalence figures >10%.
It is really difficult to properly draw the line, and until we figure out clear biological markers it is nearly impossible. But the line needs to be drawn somewhere.
It is terrible that people with symptoms that ressemble ME are being psychologised unfairly. However, it is not scientifically prudent to include these people in ME criteria simply for that reason, as it leads to a slippery slope which can water down definitions so much they don’t mean anything anymore.
The problem, in my opinion, very clearly lies with how medicine is structured/prejudiced, and not with current ME diagnostic criteria. The only way we can get objective diagnostic criteria is if we find a biomarker. Until then, the best we can do is group patients by symptoms and other characteristics.
Further down the spectrum, are people who are functionally limited by unexplained fatigue that seems to get worse with activity. Using this definition you get much higher percentages, and biological abnormalities are much harder to find because the population becomes much more heterogenous.
If you water this down even more, you get the kind of thing we saw in that iranian study, basically just fatigue, and you start having really high prevalence figures >10%.
It is really difficult to properly draw the line, and until we figure out clear biological markers it is nearly impossible. But the line needs to be drawn somewhere.
It is terrible that people with symptoms that ressemble ME are being psychologised unfairly. However, it is not scientifically prudent to include these people in ME criteria simply for that reason, as it leads to a slippery slope which can water down definitions so much they don’t mean anything anymore.
The problem, in my opinion, very clearly lies with how medicine is structured/prejudiced, and not with current ME diagnostic criteria. The only way we can get objective diagnostic criteria is if we find a biomarker. Until then, the best we can do is group patients by symptoms and other characteristics.
Last edited: